FOXO TECHNOLOGIES INC. Increase (Decrease) in Prepaid Expense
FOXO TECHNOLOGIES INC. (FOXO) reported Increase (Decrease) in Prepaid Expense of $110.63 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. increase (decrease) in prepaid expense for the quarter ending 2026-06-30 was $85.57K, a 2108.93% increase year-over-year.
- FOXO TECHNOLOGIES INC. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was $25.06K.
- FOXO TECHNOLOGIES INC. increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was $36.51K.
- FOXO TECHNOLOGIES INC. increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was $1.35K, a 99.09% decline year-over-year.
- FOXO TECHNOLOGIES INC. increase (decrease) in prepaid expense for fiscal 2025 was $36.50K.
- FOXO TECHNOLOGIES INC. increase (decrease) in prepaid expense for fiscal 2024 was -$98.56K.
- FOXO TECHNOLOGIES INC. increase (decrease) in prepaid expense for fiscal 2021 was -$237.30K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 8 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $85.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $110.63K 10-Q · filed 2026-08-14 | $147.14K derived: sum of 3 quarters · filed 2026-08-14 | $148.50K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $25.06K 10-Q · filed 2026-05-15 | $61.57K derived: sum of 2 quarters · filed 2026-05-15 | $62.92K derived: sum of 3 quarters · filed 2026-05-15 | $66.80K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $36.51K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $37.86K derived: sum of 2 quarters · filed 2026-04-15 | $41.74K derived: sum of 3 quarters · filed 2026-08-14 | $36.50K 10-K · filed 2026-04-15 | |
| 2025-09-30 | $1.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $5.23K derived: sum of 2 quarters · filed 2026-08-14 | -$15.00 10-Q · filed 2025-11-10 | -$185.40K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $3.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.37K 10-Q · filed 2026-08-14 | -$186.75K derived: sum of 3 quarters · filed 2026-08-14 | -$38.61K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$5.24K 10-Q · filed 2026-05-15 | -$190.63K derived: sum of 2 quarters · filed 2026-05-15 | -$42.48K derived: sum of 3 quarters · filed 2026-05-15 | -$45.23K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$185.38K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$37.24K derived: sum of 2 quarters · filed 2026-04-15 | -$39.99K derived: sum of 3 quarters · filed 2026-04-15 | -$98.56K 10-K · filed 2026-04-15 | |
| 2024-09-30 | $148.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $145.40K derived: sum of 2 quarters · filed 2025-11-10 | $86.82K 10-Q · filed 2025-11-10 | ||
| 2024-06-30 | -$2.75K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2025-08-19 | -$61.32K 10-Q · filed 2025-08-19 | |||
| 2024-03-31 | -$58.57K 10-Q/A · filed 2025-08-19 | ||||
| 2022-06-30 | -$30.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$108.19K 10-Q · filed 2022-08-12 | -$110.44K derived: sum of 3 quarters · filed 2022-08-12 | -$194.19K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2022-03-31 | -$77.44K 10-Q · filed 2022-05-16 | -$79.68K derived: sum of 2 quarters · filed 2022-05-16 | -$163.43K derived: sum of 3 quarters · filed 2022-05-16 | -$250.17K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-12-31 | -$2.25K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | -$86.00K derived: sum of 2 quarters · filed 2022-03-07 | -$172.74K derived: sum of 3 quarters · filed 2022-08-12 | -$237.30K 10-K · filed 2022-03-07 | |
| 2021-09-30 | -$83.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$170.49K derived: sum of 2 quarters · filed 2022-08-12 | -$235.06K 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | -$86.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$151.31K 10-Q · filed 2022-08-12 | |||
| 2021-03-31 | -$64.57K 10-Q · filed 2022-05-16 | ||||
| 2020-12-31 | $471.56K 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |